These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16505516)

  • 1. Association of serum proinsulin with hormone replacement therapy in nondiabetic older women: the Rancho Bernardo Study.
    Kim DJ; Barrett-Connor E
    Diabetes Care; 2006 Mar; 29(3):618-24. PubMed ID: 16505516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in the association between proinsulin and intact insulin with coronary heart disease in nondiabetic older adults: the Rancho Bernardo Study.
    Oh JY; Barrett-Connor E; Wedick NM
    Circulation; 2002 Mar; 105(11):1311-6. PubMed ID: 11901041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status. The Rancho Bernardo Study, 1984-1987.
    Ferrara A; Barrett-Connor E; Wingard DL; Edelstein SL
    Diabetes Care; 1995 Feb; 18(2):220-5. PubMed ID: 7729301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiazide-associated metabolic abnormalities and estrogen replacement therapy: an epidemiological analysis of postmenopausal women in Rancho Bernardo, California.
    Saxman KA; Barrett-Connor EL; Morton DJ
    J Clin Endocrinol Metab; 1994 May; 78(5):1059-63. PubMed ID: 8175960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance.
    Davies MJ; Rayman G; Gray IP; Day JL; Hales CN
    Diabet Med; 1993 May; 10(4):313-20. PubMed ID: 8508612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type A behavior pattern, heart disease risk factors, and estrogen replacement therapy in postmenopausal women: the Rancho Bernardo Study.
    Buller JC; Kritz-Silverstein D; Barrett-Connor E; Wingard D
    J Womens Health; 1998 Feb; 7(1):49-56. PubMed ID: 9511132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of insulin resistance on proinsulin secretion in pregnancy: hyperproinsulinemia is not a feature of gestational diabetes.
    Retnakaran R; Hanley AJ; Sermer M; Zinman B
    Diabetes Care; 2005 Nov; 28(11):2710-5. PubMed ID: 16249544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III).
    Crespo CJ; Smit E; Snelling A; Sempos CT; Andersen RE;
    Diabetes Care; 2002 Oct; 25(10):1675-80. PubMed ID: 12351460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipoprotein levels and plasma concentrations of insulin, intact and 32, 33 split proinsulin in normoglycaemic relatives of patients with type 2 diabetes.
    Gelding SV; Andres C; Niththyananthan R; Richmond W; Gray IP; Johnston DG
    Diabet Med; 1994 Oct; 11(8):748-54. PubMed ID: 7851068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.
    Lambert LJ; Straton JA; Knuiman MW; Bartholomew HC
    J Epidemiol Community Health; 2003 Apr; 57(4):294-300. PubMed ID: 12646547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study.
    Festa A; D'Agostino R; Mykkänen L; Tracy RP; Hales CN; Howard BV; Haffner SM
    Diabetes Care; 1999 Oct; 22(10):1688-93. PubMed ID: 10526736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study.
    Park S; Barrett-Connor E; Wingard DL; Shan J; Edelstein S
    Diabetes Care; 1996 May; 19(5):450-6. PubMed ID: 8732708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition.
    Hanley AJ; McKeown-Eyssen G; Harris SB; Hegele RA; Wolever TM; Kwan J; Connelly PW; Zinman B
    Diabetes Care; 2001 Jul; 24(7):1240-7. PubMed ID: 11423509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study.
    Mooy JM; Grootenhuis PA; de Vries H; Kostense PJ; Popp-Snijders C; Bouter LM; Heine RJ
    Diabetologia; 1996 Mar; 39(3):298-305. PubMed ID: 8721775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study.
    Jernström H; Barrett-Connor E
    J Womens Health Gend Based Med; 1999 Dec; 8(10):1265-72. PubMed ID: 10643834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study.
    Barrett-Connor E; Ferrara A
    Diabetes Care; 1998 Aug; 21(8):1236-9. PubMed ID: 9702426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil?
    Temelkova-Kurktschiev T; Henkel E; Schaper F; Koehler C; Siegert G; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2000; 108(2):93-9. PubMed ID: 10826515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study.
    Oh JY; Barrett-Connor E; Wedick NM; Wingard DL;
    Diabetes Care; 2002 Jan; 25(1):55-60. PubMed ID: 11772901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and glucose metabolism.
    Triusu RJ; Cowie CC; Harris MI
    Obstet Gynecol; 2000 Nov; 96(5 Pt 1):665-70. PubMed ID: 11042298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM.
    Haffner SM; Bowsher RR; Mykkänen L; Hazuda HP; Mitchell BD; Valdez RA; Gingerich R; Monterossa A; Stern MP
    Diabetes; 1994 Dec; 43(12):1490-3. PubMed ID: 7958504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.